Make room for meaningful change.

Start with the life you want to build.

Our conversation begins with your priorities: habits you want to establish, patterns you want to shift, and how you want to feel and function in everyday life.

• Creating more consistent routines around sleep, movement, and nutrition.
• Working toward a different relationship with cravings and automatic behaviours.
• Developing practical ways to respond to stress and emotional triggers.
• Exploring concerns about focus, motivation, and mental fatigue.

These are goals to explore together. They help shape your assessment and how we track progress.

rTMS, ExoMind & Health Canada approval.

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive approach that delivers magnetic pulses to targeted brain regions. At Healthcode, the ExoMind system is used within a broader program of individualized health support.

We can discuss whether it has a role in your plan. Evidence and authorized indications differ by condition; benefits for general optimization or habit change are less established. The goals described here are not a promise of treatment outcomes.

Health Canada-approved ExoMind technology

ExoMind is a Health Canada-licensed medical device. The manufacturer’s Canadian labeling identifies the following intended uses:

• Major depressive disorder (MDD). For adults who have not achieved satisfactory improvement after an adequate antidepressant medication trial in the current episode.
• Anxiety symptoms associated with MDD. Reduction of co-occurring anxiety symptoms in people with major depressive disorder.
• Obsessive-compulsive disorder (OCD). Adjunctive treatment for adults with OCD.
• Binge-eating disorder (BED). Considered after reviewing the diagnosis, treatment history, and individual suitability.

EXOMIND · Health Canada medical device licence 111940. Health Canada licence listing ↗ · Manufacturer’s Canadian labeling and patient information ↗

Off-label uses & optimization goals

Off-label use means use outside the device’s authorized indications. Whether a proposed use is off-label depends on the diagnosis and treatment protocol. Healthcode also discusses the following concerns and goals in individual consultations:

• Brain fog & cognitive fatigue. Including concerns arising after illness, such as Long COVID.
• Sleep difficulties. Exploring insomnia or disrupted sleep alongside other possible contributors.
• Mood changes around life transitions. Including perimenopause, menopause, or postpartum concerns, with appropriate clinical assessment.
• Burnout, low motivation & mental exhaustion. Considered in the context of work, stress, sleep, and overall health.
• Behavioural change & optimization. Goals involving focus, daily routines, emotional resilience, and follow-through.

Evidence varies across these uses and is less established for general optimization. Device approval does not establish effectiveness for every off-label goal. We discuss the research, uncertainty, alternatives, and what meaningful progress would look like for you.

Connect treatment with everyday action.

The broader plan considers sleep, nutrition, physical activity, social connection, stress management, and clinically appropriate medication or supplement review.

• Sleep. Review timing, consistency, and obstacles to restorative rest.
• Nutrition. Develop sustainable eating patterns around your needs and circumstances.
• Physical activity. Build a manageable approach to movement.
• Social connection. Consider relationships, support, and everyday opportunities for connection.
• Stress management. Practise strategies that fit the pressures of your life.
• Medication & supplement review. Review potential benefits, interactions, and ongoing need with your treating practitioners.

Together, we translate your priorities into manageable actions and revisit what is helping. Your lived experience and progress toward your own goals remain central to the conversation.

A thoughtful assessment comes first.

A consultation reviews your health history, medications, previous care, and suitability for stimulation. This includes screening for relevant implants, seizure risk, and other contraindications. We discuss potential side effects, alternatives, and what a course of care would involve before you decide.

What to expect

You remain awake and seated or reclined while an applicator is positioned at the scalp. Sessions typically last less than 30 minutes. You may feel tapping or tingling; treatment does not require an anesthetic. The number and spacing of visits are discussed after assessment.

Potential side effects include headache or scalp discomfort. Seizures and mood elevation, including hypomania, are important risks to discuss during screening. You are monitored during treatment, and response and ongoing care needs are reviewed over time.

Explore the clinic program.

Read more about the technology and program at Healthcode ExoMind ↗.